|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits at other banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost of $206,888 and $199,127, respectively) | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost (fair value of $30,117 and $30,152, respectively) | ||||||||||||||||||||
| Equity investments | ||||||||||||||||||||
| Mortgage loans held for sale | ||||||||||||||||||||
| Loans and other finance receivables, net of fees and costs | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans and other finance receivables, net of the allowance for credit losses | ||||||||||||||||||||
| Restricted investment in bank stock | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| OREO and other repossessed assets | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Servicing assets | ||||||||||||||||||||
| Servicing assets held for sale | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $1 par value per share. $25,000,000 shares authorized; $13,188,698 and $13,186,198 shares issued and $11,185,515 and $11,183,015 shares outstanding, respectively | ||||||||||||||||||||
| Common stock, $1 par value: $25,000,000 shares authorized; 13,926,981 and 13,829,645 shares issued, respectively, and 11,923,798 and 11,826,462 shares outstanding, respectively | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Treasury stock, 2,003,183 shares, at cost | ||||||||||||||||||||
| Unearned common stock held by ESOP | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Treasury stock held (in shares) | ||||||||||||||||||||
| Common Stock, Shares, Outstanding | ||||||||||||||||||||
| Common Stock, Shares, Issued | ||||||||||||||||||||
Loading...